NCT04043702

Combination of Topiramate and Empagliflozin is Considered a Good Option for the Treatment of Obesity

Combination of Topiramate(Conviban) and Empagliflozin(Jardiance) is Considered a Good Option for the Treatment of Obesity

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 200 (actual)
• Sponsor: Ministry of Health and Population, Egypt · Other Government
• Sex: All
• Age: 30 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The aim was to show if a combination of topiramate and empagliflozin have the greatest weight decreasing effect in comparison to each drug alone and to group with no treatment( control group). .

Detailed description

The aim was to show if a combination of topiramate and empagliflozin have the greatest weight decreasing effect in comparison to each drug alone and to group with no treatment( control group). Materials and methods 200 obese patients 4 groups. had been monitored in a private clinic, each group 50 patients number, with 35 females and 15 males who were already on treatment.

Conditions

• Obesity

Interventions

Type	Name	Description
DRUG	The intervention being studied	Intervention Other Names have not been specified

Timeline

• Start date: 2019-01-04
• Primary completion: 2019-07-20
• Completion: 2019-07-29
• First posted: 2019-08-02
• Last updated: 2019-08-02

Locations

1 site across 1 country: Egypt